Clinicopathological and biological features of papillary thyroid carcinoma coexisted with lymphocytic thyroiditis

梁军,赵丹,梁智勇,孟超,林岩松

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2013.17.014

2013-01-01

Abstract:OBJECTIVE:To explore and analyze the clinicopathological and biological features of papillary thyroid carcinoma concurrent with lymphocytic thyroiditis.METHODS:Totally 262cases of PTC patients were divided into group A(PTC with LT,n=77)and group B(PTC without LT,n=185).Ages,gender,tumor sizes,extrathyroidal invasion,multifocality,lymph node metastasis,distant metastasis and TNM stages were collected for analysis.BRAFV600Emutation and RET expression was detected by RT-PCR and IHC(immunohistochemistry).RESULTS:LT was confirmed in29.39% of all PTC patients.The cohort with LT revealed a higher frequency of female patients(84.42%vs 61.08%,P<0.001)and positive RET expression(76.47% vs 53.33%,P=0.001),smaller tumor size(1.32±0.74)cm vs (1.72±1.28)cm(P=0.002),a lower frequency of extrathyroidal invasion(28.57%vs 72.97%,P<0.001),distant me- tastasis(6.49%vs 16.67%,P=0.028)and BRAFV600Emutation(39.71%vs 78.52%,P<0.001).There was no signifi- cant difference between the two group in multifocality,lymph node metastasis and TNM stages.The Tgs before surgery of Group A and B were(11.52±26.46)and(48.92±167.12)ng/mL(P=0.261);Anti-Tgs were(324.06±469.50)and(64.89±160.07)IU/mL(P=0.005);Anti-TPos were(219.36±273.03)and(23.33±43.62)IU/mL(P=0.001). The Tgs after surgery(before RAI treatment)of Group A and B were(15.56±82.39)and(78.55±196.22)ng/mL(P=0.001);Anti-Tg are(226.44±315.62)and(94.07±389.71)IU/mL(P=0.019);Anti-TPos were(88.46± 120.89)and(16.54±24.79)IU/mL(P=0.013).CONCLUSIONS:RET expression is related to coexistent LT in PTC. BRAFV600Emutation is less frequent in PTC with HT than those without HT.Lymphocytic thyroiditis represents a protec- tive form of host immune response to reduce the aggressiveness of PTC.